Ex Parte Singer et alDownload PDFPatent Trial and Appeal BoardOct 11, 201813939222 (P.T.A.B. Oct. 11, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/939,222 24959 7590 PPG Industries, Inc. IP Law Group One PPG Place 39th Floor Pittsburgh, PA 15272 07/11/2013 10/11/2018 FIRST NAMED INVENTOR Debra L. Singer UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 09006914Al 9914 EXAMINER PATTERSON, MARC A ART UNIT PAPER NUMBER 1782 MAIL DATE DELIVERY MODE 10/11/2018 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte DEBRA L. SINGER and JOHN M. DUDIK Appeal2017-011664 Application 13/939,222 Technology Center 1700 Before KAREN M. HASTINGS, DONNA M. PRAISS, and JANEE. INGLESE, Administrative Patent Judges. PRAISS, Administrative Patent Judge. DECISION ON APPEAL 1 STATEMENT OF THE CASE Appellant2 appeals under 35 U.S.C. § 134(a) from the Examiner's decision to reject claims 1-5, 7, 9-12, 14--20, 22, 24--27, and 29-32 under 35 U.S.C. § 103. Br. l; Final Act. 3-8. We have jurisdiction under 35 U.S.C. § 6(b ). We AFFIRM. 1 In this Decision, we refer to the Specification filed July 11, 2013 ("Spec."), the Final Office Action entered June 14, 2016 ("Final Act."), the Appeal Brief filed November 3, 2016 as corrected November 29, 2016 ("Br."), the Declaration of Gregory J. McCollum dated July 24, 2016 ("McCollum Deel."), and the Examiner's Answer entered June 12, 2017 ("Ans."). 2 Appellant/ Applicant is PPG Industries Ohio, Inc., which is also identified in the Appeal Brief as the real party in interest. Br. 1. Appeal 2017-011664 Application 13/939,222 The invention relates to a composition useful for coating containers, including food and beverage containers. Spec. ,r 1. Claim 1 is illustrative: 1. An aqueous coating composition comprising: (A) an aqueous polymer dispersion comprising a film- forming polymer in the form of dispersed polymer particles comprising a polymer phase P1 and a different polymer phase P2; the polymer dispersion obtained by free radical aqueous emulsion polymerization in aqueous medium comprising the following steps: (i) polymerizing in non-aqueous medium a first monomer charge Ml comprising a polymerizable ethylenically unsaturated monomer mixture comprising 15 to 60 percent by weight of a carboxylic acid group-containing ethylenically unsaturated monomer and 2 to 20 percent by weight of a phosphorus acid group-containing ethylenically unsaturated monomer, the percentages by weight being based on total weight of the ethylenically unsaturated monomers in M 1, to form the polymer phase P1; (ii) at least partially neutralizing the carboxylic acid groups with an amine in the aqueous medium, and (iii) polymerizing in the aqueous medium a second monomer charge M2 in the presence of P 1 comprising a polymerizable ethylenically unsaturated monomer mixture different from that of Ml and containing a 1,2-epoxy group- containing ethylenically unsaturated monomer to form the polymer phase P2; (B) a curing agent reactive with the film-forming polymer. Br. 7 (Claims Appendix). Claim 16, the only other independent claim among the claims on Appeal, is directed to a food can coated at least in part with a coating deposited from the aqueous coating composition of claim 1. Id. at 9. 2 Appeal 2017-011664 Application 13/939,222 The Examiner maintains and Appellant appeals the following rejections under 35 U.S.C. § 103: 3 1. Claims 1, 2, 7, 9--12, and 15 over Huybrechts; 4 2. Claims 3-5 over Huybrechts in view ofNaka; 5 3. Claims 14, 16, 17, 22, 24--27, and 29--32 over Huybrechts in view of 0 'Briell" 6 and ' 4. Claims 18-20 over Huybrechts in view of O'Brien and Naka. Ans. 2---6; Final Act. 4--8; Br. 3. OPINION We review the appealed rejections for error based upon the issues identified by Appellant and in light of the arguments and evidence produced thereon. See Ex parte Frye, 94 USPQ2d 1072, 1075 (BPAI 2010) (precedential), cited with approval in In re Jung, 637 F.3d 1356, 1365 (Fed. Cir. 2011) ("it has long been the Board's practice to require an applicant to identify the alleged error in the examiner's rejections"). After review of the arguments and evidence presented by both Appellant and the Examiner, we conclude that the claim limitations recited in claim 1 are so indefinite as to require us to make assumptions about the meaning of the terms employed in order to determine the scope of the claim. Rejection 1: Obviousness over Huybrechts The Examiner determines that claims 1, 2, 7, 9--12, and 15 would have been obvious to one of ordinary skill in the art at the time of the invention 3 The rejections of claims 1 and 16 under 35 U.S.C. § 112(b) as indefinite have been withdrawn. Advisory Action dated August 31, 2016, 2. 4 Huybrechts et al., WO 95/32228, published Nov. 20, 1995 ("Huybrechts"). 5 Naka et al., JP 2008115339, published May 22, 2008 ("Naka"). 6 O'Brien et al., WO 2006/045017 Al, published Apr. 27, 2006 ("O'Brien"). 3 Appeal 2017-011664 Application 13/939,222 over Huybrechts for the reasons stated on pages 4--6 of the Final Office Action. Appellant argues the claims as a group (Br. 4--5). In accordance with 37 C.F.R. § 4I.37(c)(l)(iv), claims 2, 7, 9--12, and 15 will stand or fall together with independent claim 1 from which they depend. Appellant contends that the Examiner erred in two respects ( 1) finding that Huybrechts' hydrophobic backbone corresponds to the recited P 1 phase and that the macromonomer side chains correspond to polymer phase P2 and (2) finding that Dr. McCollum has not addressed the phosphoric acid group- containing monomer is disclosed by Huybrechts in amounts up to 50% by weight, which overlaps the claimed range of 2-20% by weight of a phosphorus acid group-containing ethylenically unsaturated monomer. Br. 5. Appellant asserts that Huybrechts' hydrophobic backbone polymer is analogous to the claimed P2 phase, not the P 1 phase. Id. According to Appellant, there is no dispute that Huybrechts discloses phosphorus acid- containing ethylenically unsaturated monomers of the type required for polymer phase P1, but argues that Huybrechts teaches such monomers in the formation of the hydrophobic backbone, which is analogous to the claimed P2 phase. Id. Appellant notes that Huybrechts teaches that the macromonomer can first be dispersed in aqueous medium followed by polymerization of the hydrophobic monomers. Id. ( citing Huybrechts 12: 1- 33). Paragraph 8 of the McCollum Declaration describes the claimed polymers as "core/shell polymers" in which the P 1 phase is hydrophilic and forms the shell of the polymer in the aqueous medium. McColl um Deel. ,r 8. The hydrophilic groups are said to be neutralized carboxylic acid and phosphorus acid groups that are drawn to the surrounding aqueous phase and 4 Appeal 2017-011664 Application 13/939,222 available to bond to the surface of a substrate (an adhesion-promoting effect). Id. The P2 phase, on the other hand, is said to be hydrophobic relative to the P 1 phase and forms a core that is shielded from the surrounding aqueous medium. Id. Regarding the amount of phosphoric acid group-containing monomer disclosed by Huybrechts, Appellant contends that Huybrechts teaches that the hydrophobic backbone can contain up to 50% of methacrylates and up to 50% by weight of graft copolymer of polymerized ethylenically unsaturated non-hydrophobic monomers which may contain reactive functional groups. Br. 5. According to Appellant, other vinyl monomers can be incorporated into the backbone and include phosphoric acid or phosphonic acid group- containing monomers, however, these monomers do not have reactive functional groups, and, if present, are present in an undisclosed amount. Id. (citing Huybrechts 8:6-23). The Examiner responds that a core/shell structure is not claimed nor do the claims explicitly require that the P1 phase is hydrophilic or that the P2 phase is hydrophobic. Ans. 8. The Examiner further responds that the claims do not exclude a P2 phase that has the same neutralized carboxylic acid and phosphoric acid groups as the P 1 phase, therefore, it is not clear that in aqueous medium the P1 phase would form an outer shell and the P2 phase would form an inner core. Id. The Examiner also points out that neutralized phosphoric acid groups are not claimed. Id. Regarding the amount of phosphoric acid group-containing monomer disclosed by Huybrechts, the Examiner finds that Huybrechts teaches 0-50% by weight for the amount of ethylenically unsaturated monomers which may contain reactive functional groups. Id. The Examiner also finds that the 5 Appeal 2017-011664 Application 13/939,222 phosphoric or phosphonic acid group-containing monomers disclosed by Huybrechts do have reactive functional groups, because acid functionality is reactive with any functionality that neutralizes acid. Id. The Examiner further finds that Huybrechts does not indicate that a lack of reactive functional groups prevents the amount of phosphoric or phosphonic acid group-containing monomers from being within the range of 0-50% by weight. Id. After considering the positions and evidence of both Appellant and the Examiner, we find that the preponderance of the evidence cited in this Appeal record supports the Examiner's rejection of claim 1 under 35 U.S.C. § 103 over Huybrechts. Claim 1 is directed to a composition. As such, the limitations in claim 1 directed to the processing conditions are only meaningful to the extent they serve to differentiate the structure of the claimed composition from the structure of the prior art composition. See In re Thorpe, 777 F.2d 695, 697 (Fed. Cir. 1985) (internal citations omitted) (noting that "even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in a product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process"). Appellant has not provided convincing evidence of a patentable difference in structure between the composition of claim 1 and that suggested by the prior art. Based on the record cited in this Appeal, the core/shell structure described in paragraph 8 of the McCollum Declaration would not necessarily result from the process steps recited in claim 1 6 Appeal 2017-011664 Application 13/939,222 because the claim does not require neutralized phosphoric acid groups or a P2 phase that is hydrophobic or less hydrophilic than the P 1 phase, nor does the claim exclude a P2 phase that has the same neutralized carboxylic acid and phosphoric acid groups as the P 1 phase. Appellant does not rebut the Examiner's findings in regard to the processing conditions recited in claim 1 encompassing a composition that does not form a core/shell structure. Accordingly, Appellant's distinctions over Huybrechts' composition on this basis are not persuasive of error by the Examiner because limitations not appearing in the claims cannot be relied upon for patentability. In re Self, 671 F.2d 1344, 1348 (CCPA 1982). In addition, the Examiner's finding that Huybrechts discloses an overlapping amount (0-50% by weight) of ethylenically unsaturated monomers which may contain reactive functional groups, and, specifically, phosphoric or phosphonic acid group-containing monomers that do have reactive functional groups because acid functionality is reactive with any functionality that neutralizes acid, is reasonable and supported by the record. Ans. 2, 8; Huybrechts 8:6-20. The Examiner's finding that the carboxylic acid groups are at least partially neutralized with an amine in Huybrechts' process (Ans. 3) is also supported by the record and not disputed by Appellant. Huybrechts 12: 1-14. For the foregoing reasons and those provided in the Final Office Action and the Answer, Appellant's arguments are unpersuasive as to error in the rejection of claims 1, 2, 7, 9-12, and 15 under 35 U.S.C. § 103. 7 Appeal 2017-011664 Application 13/939,222 Rejection 2: Obviousness over Huybrechts and Naka The Examiner determines that claims 3-5 would have been obvious to one of ordinary skill in the art at the time of the invention over Huybrechts in view ofNaka for the reasons stated on page 6 of the Final Office Action. Claim 3 depends from claim 1 and recites "the phosphorus acid group-containing ethylenically unsaturated monomer has the following structure: i -~:: c~ .-.·,-. f> w·· r\~ .... x:. where R1 represents hydrogen or methyl; R2 represents a polyoxyalkylene group and X represents a phosphoric acid group." Br. 7-8 (Claims Appendix). Appellants argue the rejection of claims 3-5 as a group (Br. 6). Accordingly, claims 4 and 5 will stand or fall together with claim 3 from which they depend. 37 C.F.R. § 4I.37(c)(l)(iv). Appellant contends that the Examiner erred because N aka does not disclose using the monomer required by claim 3 in forming the final polymer, but, rather, discloses dimerizing the particular monomer to form a phosphoric acid group-containing monomer having the following structure: ~: :~ : ~ ~t~(; ~~ f; .... l; ~., {{)f()>:x':: N-' () ,W tt ,-.',> ()~f !:,\(; ·:;::· (~ -~'"· (~ '·" {()f{~~~:":~~~ ,,.,,. () ! . H ({~ () 8 Appeal 2017-011664 Application 13/939,222 Br. 4, 5. Appellant further asserts that Naka discloses extremely high amounts of the dimerized phosphoric acid group-containing monomer, i.e., 70-97 .5% versus 2-20% as claimed. Id. at 6. The Examiner responds that N aka discloses a mixture of the monomer and the dimer comprising 0.5% dimer by weight, therefore Naka is not limited to the dimer even though dimerization is taught. Ans. 9 ( citing Naka ,r 39). The Examiner further responds that Naka teaches that the amount of the monomer to be copolymerized with another monomer is preferably 70- 97.5% by weight, therefore Naka is not limited to that preferred range. Id. We have fully considered Appellant's arguments and do not find them persuasive of error by the Examiner because the Examiner's findings are supported by the record. The dimer monomer to which Appellant directs us is referred to in N aka as "monomer 2" while N aka' s "monomer 1" is not a dimer. Naka ,r 7. The Examiner's finding that Naka discloses a preferred composition in which the dimer is 5% of the monomer composition is supported by the record. Naka ,r 39. The Examiner's finding that Naka is not limited to the high range of phosphoric acid group-containing monomer asserted by Appellant is also supported by the record because N aka discloses that it is a preferred range, stating "[ t ]he total amount of monomer 1 and monomer 2 in the monomer used for polymerization is preferably at least 70 wt. %, more preferably at least 80 wt.%, still more preferably at least 85 wt.%, furthermore at least 95 wt.% and still further at least 97.5 wt.%." Naka ,r 42. Moreover, the Examiner finds that Huybrechts discloses the amount of phosphoric acid group-containing monomer required by independent claim 1 from which claim 3 depends. Final Act. 4 ( citing 9 Appeal 2017-011664 Application 13/939,222 Huybrechts 9:19--29). Accordingly, we are not persuaded of reversible error in the Examiner's findings regarding the disclosures ofNaka. For the foregoing reasons and those provided in the Final Office Action and the Answer, Appellant's arguments are unpersuasive as to error in the rejection of claims 3-5 under 35 U.S.C. § 103. Rejections 3 and 4: Obviousness over Huybrechts, 0 'Brien, and Naka Appellant asserts that the Examiner's rejections of claims 14, 16-20, 22, 24--27, and 29-32 should be reversed in view of the shortcomings associated with Huybrechts and Naka as discussed above in connection with Rejections 1 and 2. Br. 6. Because we do not find Appellant's arguments persuasive of error by the Examiner for the reasons discussed above, we likewise affirm the Examiner's rejections of claims 14, 16-20, 22, 24--27, and 29--32. Conclusion Appellant has not shown that the Examiner erred in rejecting claims 1-5, 7, 9--12, 14--20, 22, 24--27, and 29-32. DECISION The decision of the Examiner to reject claims 1-5, 7, 9--12, 14--20, 22, 24--27, and 29-32 is affirmed. 10 Appeal 2017-011664 Application 13/939,222 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). ORDER AFFIRMED 11 Copy with citationCopy as parenthetical citation